Character | Response | |
---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
Character | Response | |
---|---|---|
|
|
|
|
|
|
|
|
|
Class | Active | Resistant |
---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
N/A
Non-digestible carbohydrates generally provide the main sources of energy for the microbial communities that inhabit the human large intestine. These include plant cell wall polysaccharides such as cellulose, xylan and pectin that comprise plant fiber, but on most diets the largest contribution is thought to come from the fraction of dietary starch that survives digestion in the upper gastrointestinal tract (resistant starch, RS). This work also indicates that R. bromii possesses an exceptional ability to colonize and degrade starch particles when compared with previously studied amylolytic bacteria from the human colon. [PMID: 22343308]
Ruminococcaceae are an important family of Firmicutes bacteria within the colonic microbial communities which have evolved specialized systems to utilize complex carbohydrates. R. bromii is one of the most abundant bacteria constituting the human colonic microbiota and a primary degrader of starch resistant (RS), an important non-digestible dietary polysaccharide. [PMID: 30455672]
Moore, W. E. C., Cato, E. P., & Holdeman, L. V. (1972). Ruminococcus bromii sp. n. and Emendation of the Description of Ruminococcus Sijpestein. International Journal of Systematic Bacteriology, 22(2), 78–80.
Lineage | Physiology | General | Growth Tolerances | Hydrol./digest./degr. |
|
|
Health:
Positive
Source: human faeces
DNA G+C(%): 39–40
|
|
|
---|
Monosaccharide O/F | Oligosaccharide O/F | Polysaccharide O/F | Polyol O/F | Other O/F |
|
|
|
|
|
---|
Monosaccharide util/assim | Oligosaccharide util/assim | Other carboh. util/assim | Amino acid util/assim | Organic acid util/assim |
|
|
|
|
|
---|
Enzymes: General | Enzymes: Carbohydrate | Enzymes: Protein | Enzymes: Arylamidases | Enzymes: Esters/fats |
|
|
|
|
|
---|
Fuel | Usable Metabolites | Metabolites Released | Special Products | Compounds Produced |
|
---|
Penicillins & Penems (μg/mL) | Cephalosporins (μg/mL) | Aminoglycosides (μg/mL) | Macrolides (μg/mL) | Quinolones (μg/mL) |
amoxicillin: Sens
ampicillin: Sens
azlocillin: Sens
aztreonam: Res
bacampicillin: Sens
benzyl-pen: Sens
cloxacillin: Sens
dicloxacillin: Sens
oxacillin: Sens
piperacillin: Sens
ticarcillin: Sens
imipenem: Sens
meropenem: Sens
|
cefaclor: Sens
cefadroxil: Res
cefazolin: Sens
cefdinir: Sens
cefepime: Sens
cefixime: Sens
cefmetazole: Sens
cefoperazone: Sens
cefotaxime: Sens
cefotetan: Sens
cefotiam: Sens
cefoxitin: Sens
ceftazidime: Sens
cefuroxime: Sens
cephalothin: Sens
moxalactam: Sens
|
amikacin: Sens
dihydrostrept: Res
gentamicin: Res
kanamycin: Res
neomycin: Res
sisomicin: Res
spectinomycin: Res
streptomycin: Res
tobramycin: Sens
|
azithromycin: Sens
erythromycin: Sens
clarithromycin: Sens
roxithromycin: Sens
spiramycin: Sens
josamycin: Sens
|
linezolid: Sens
ciprofloxacin: Sens
clavulanate: Sens
clinafloxacin: Sens
enoxacin: Res
gatifloxacin: Sens
moxifloxacin: Sens
nalidixic-acid: Res
norfloxacin: Res
ofloxacin: Res
pefloxacin: Res
pipemidic_acid: Res
sarafloxacin: Sens
sparfloxacin: Res
|
---|---|---|---|---|
Tetracyclines (μg/mL) | Vancomycin Class (μg/mL) | Polypep/ketides (μg/mL) | Heterocycles (μg/mL) | Other (μg/mL) |
doxycycline: Sens
chlortetracycline: Sens
meclocycline: Sens
methacycline: Sens
minocycline: Sens
oxytetracycline: Sens
tetracycline: Sens
|
vancomycin: Sens
|
bacitracin: Sens
rifabutin: Sens
rifampicin: Sens
rifapentine: Sens
|
chloramphenicol: Sens
isoniazid: Res
metronidazole: Sens
nitrofurantoin: Sens
sulfadiazine: Res
sulfadimethoxine: Res
sulfamethoxazole: Res
sulfanilamide: Res
trimethoprim: Res
|
clindamycin: Sens
lincomycin: Sens
colistin: Res
fusidic-acid: Sens
|